# LLM Judge Evaluation: tier3_006

## Overall: FAIL

### Scores:
- **Completion**: 1/2
- **Correctness**: 0/2
- **Tool Use**: 0/2
- **Total**: 1/6

### Reasoning:
Completion:
- Geometry optimization, descriptor, solubility, and docking workflows were all submitted; most reached COMPLETED_OK. However, the agent never retrieved descriptor outputs, did not present any geometry (coordinates/energy), and failed to report the requested water solubility results (it retrieved and reported an organic-solvent run instead). Docking first failed, then succeeded, but on the wrong protein. Overall: partially complete.

Correctness:
- Descriptors: MW correct; logP off by ~0.53 units vs experimental; TPSA notably higher than reputable predicted value.
- Solubility: The user asked for water at multiple temperatures; the answer reported organic solvents and omitted water. Literature water solubility for benzylpenicillin at 25 °C is ~210 mg/L; no computed water value was provided to compare.
- Docking: Major factual error. The agent ran docking on PDB 1HCK (CDK2, a human kinase) and then claimed results for “β‑lactamase (PDB 4E2O)”; 4E2O is an α‑amylase, not a β‑lactamase. Thus the docking conclusions about resistance are invalid.

Tool Use:
- Correct classes of tools were used and runs were monitored. But there were multiple critical parameter/target mistakes: wrong protein, pocket definitions that caused a failure, an incorrect solvent set for the solubility task, and two 404 retrieval attempts. This indicates poor parameter validation and target verification.

### Feedback:
- Verify targets before docking. 1HCK is CDK2, and 4E2O is an α‑amylase; neither is a β‑lactamase. Use a bona fide β‑lactamase (e.g., TEM‑1 1BTL or PER‑2 4D2O) and define the pocket from the catalytic Ser/Lys/Glu/Asn active-site region or a co-crystallized ligand.
- Fulfill the specified solvent/temperature. The task requested water at multiple temperatures; retrieve and report the completed water-solubility run instead of an unrelated organic-solvent job. Include units and uncertainty.
- Retrieve and report from the tool outputs. Do not hand-enter descriptors; fetch the descriptor results and include key values (MW, logP, TPSA, HBD/HBA, rotatable bonds), with the exact workflow UUIDs.
- For geometry optimization, report final energy and provide either coordinates or a confirmation of convergence criteria; if relevant, follow with a frequency check to verify a minimum.
- For docking, include pose quality checks (clashes, key H-bonds/salt bridges), binding-mode rationalization versus known β‑lactamase mechanisms (e.g., acylation of Ser70), and cite the correct PDB entry.
- Validate parameters to avoid failures (pocket boxes should be center+size or two corners consistently; initial failure indicated malformed inputs).
- Literature validation: - Molecular weight
  1) Agent: 334.39 g/mol
  2) Literature: 334.39 g/mol (ACS “Molecule of the Week”) 
  3) Abs. error: 0.00
  4) % error: 0.00%
  5) Score justification: Exact match. ([acs.org](https://www.acs.org/molecule-of-the-week/archive/b/benzylpenicillin.html?utm_source=openai))

- logP (octanol/water)
  1) Agent: 1.3
  2) Literature (experimental): 1.83 (Hansch et al., reported on DrugBank)
  3) Abs. error: 0.53
  4) % error: 28.96%
  5) Score justification: 0.3–0.8 units off → partial credit per rubric. ([drugbank.ca](https://www.drugbank.ca/drugs/DB01053))

- TPSA
  1) Agent: 121.3 Å²
  2) Literature (predicted, Chemaxon on DrugBank): 86.71 Å²
  3) Abs. error: 34.59 Å²
  4) % error: 39.9%
  5) Score justification: Large discrepancy; not a scored rubric item but indicates descriptor inaccuracy. ([drugbank.ca](https://www.drugbank.ca/drugs/DB01053))

- Water solubility at 298.15 K (25 °C)
  1) Agent: not reported (agent reported only organic solvents)
  2) Literature: 210 mg/L (free acid) 
  3) Abs. error: N/A
  4) % error: N/A
  5) Score justification: Required property omitted; cannot validate; penalizes completion/correctness. ([acs.org](https://www.acs.org/molecule-of-the-week/archive/b/benzylpenicillin.html?utm_source=openai))

- Docking target identity (factual validation)
  1) Agent: claimed docking to β‑lactamase; reported “PDB 4E2O”
  2) Literature: 1HCK is human CDK2 (not a β‑lactamase); 4E2O is a Geobacillus α‑amylase (not a β‑lactamase). Example of an actual class A β‑lactamase PDB: 4D2O (PER‑2).
  3) Abs./% error: categorical target mismatch
  4) —
  5) Score justification: Fundamental target error invalidates docking conclusions. ([rcsb.org](https://www.rcsb.org/structure/1hck?utm_source=openai))

### Web Search Citations:
1. [Benzylpenicillin - American Chemical Society](https://www.acs.org/molecule-of-the-week/archive/b/benzylpenicillin.html?utm_source=openai)
2. [Benzylpenicillin: Uses, Interactions, Mechanism of Action | DrugBank Online](https://www.drugbank.ca/drugs/DB01053)
3. [Benzylpenicillin: Uses, Interactions, Mechanism of Action | DrugBank Online](https://www.drugbank.ca/drugs/DB01053)
4. [Benzylpenicillin - American Chemical Society](https://www.acs.org/molecule-of-the-week/archive/b/benzylpenicillin.html?utm_source=openai)
5. [RCSB PDB - 1HCK: HUMAN CYCLIN-DEPENDENT KINASE 2](https://www.rcsb.org/structure/1hck?utm_source=openai)

### Execution:
- **Tools**: submit_descriptors_workflow, submit_docking_workflow, submit_basic_calculation_workflow, molecule_lookup, submit_solubility_workflow, workflow_get_status, retrieve_workflow
- **Time**: 49.5 min

---
*Evaluated with openai/gpt-5*
